ATLASBoundless Bio (BOLD) earnings date: Nov 4, 2026
Boundless Bio (BOLD) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BOLD
| Last price | $2.47 (-0.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.8% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Boundless Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Boundless Bio reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Boundless Bio. You can switch it off at any time.
Alert me before BOLD reportsFree to start. Creating an account takes under a minute.
BOLD earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 7, 2026 · Miss |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -21.2% |
| Average move around a report | ±1.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Boundless Bio earnings history: last 5 reports
Boundless Bio last reported on Aug 7, 2026: EPS of -$1.06 against an estimate of -$0.58 (-82.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.58 | -$1.06 | -82.8% | Miss | -0.7% |
| May 8, 2026 | -$0.56 | -$0.60 | -7.1% | Miss | +1.3% |
| Mar 9, 2026 | -$0.52 | -$0.58 | -11.5% | Miss | +1.8% |
| Feb 4, 2026 | $1.32 | $1.35 | +2.3% | Beat | 0.0% |
| Nov 5, 2025 | -$0.58 | -$0.62 | -6.9% | Miss | -3.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BOLD
See the fair value, the probability range and the earnings history of Boundless Bio on its ATLAS page.
Boundless Bio (BOLD) stock analysisPlans from €3.99 a month.
Boundless Bio earnings: frequently asked questions
When does Boundless Bio (BOLD) report earnings?
Boundless Bio is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does BOLD beat earnings estimates?
Of its last 5 reports with a recorded result, Boundless Bio beat the EPS estimate 1 times; the average surprise was -21.2%. Past results do not predict the next one.
How much does BOLD move around earnings?
Over its last 5 reports the stock moved an average of 1.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Boundless Bio beat earnings estimates last quarter?
Boundless Bio last reported on Aug 7, 2026: EPS of -$1.06 against an estimate of -$0.58 (-82.8% surprise), a miss.
How much does BOLD usually move in a day?
On a normal trading day the ATLAS model puts BOLD’s one-day range at about ±2.8%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer